SCHEMBL4903863

SCHEMBL4903863

COC(=O)c1cc(S(=O)(=O)NCCc2coc(-c3ccc(C(F)(F)F)cc3)n2)cc(C)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.42
PPARA Q07869 2/20 0.42
POLB P06746 3/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.36
TP53 P04637 4/20 0.36
MAPT P10636 3/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
MMP1 P03956 1/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895720 0.92 PPARG (0.40) PPARGPPARAPOLBKDM4ELMNA
SCHEMBL4911898 0.92 PPARG (0.44) PPARGPPARAPOLBKDM4ELMNA
SCHEMBL4906842 0.91 LMNA (0.45) PPARGPPARAPOLBKDM4ELMNA
SCHEMBL4903596 0.86 PPARG (0.50) PPARGPPARAPOLBKDM4ELMNA
SCHEMBL4906505 0.84 LMNA (0.46) PPARGPPARAPOLBKDM4ELMNA
SCHEMBL4907405 0.84 ALDH1A1 (0.39) PPARGPPARAPOLBKDM4ELMNA
SCHEMBL4900708 0.83 PPARG (0.41) PPARGPPARAPOLBKDM4ELMNA
SCHEMBL4895638 0.83 ERBB2 (0.44) LMNAHTTSMN1; SMN2GAATP53
SCHEMBL4900873 0.80 PPARG (0.52) PPARGPPARAPOLBKDM4ELMNA
SCHEMBL4900535 0.80 MAPT (0.41) PPARGPPARAPOLBKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885POLB 1488/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD PPARG 2/4885PPARA 1/4885POLB 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.